Ghadeer K Dawwas
#3,723,881
Most Influential Person
Researcher
Why Is Ghadeer K Dawwas Influential?
(Suggest an Edit or Addition)Ghadeer K Dawwas's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Papers
- Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis. (2019) (55)
- Cardiovascular outcomes of sodium glucose cotransporter‐2 inhibitors in patients with type 2 diabetes (2018) (43)
- Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity‐matched cohort study (2019) (30)
- Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists (2018) (20)
- Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury. (2020) (14)
- The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety (2020) (12)
- Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data (2021) (12)
- Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism. (2020) (11)
- Comparative Effectiveness and Safety of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome: A Retrospective Cohort Analysis (2019) (8)
- Long-Term Outcomes Following Multiply Recurrent Clostridioides Difficile Infection and Fecal Microbiota Transplantation. (2020) (6)
- Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations (2020) (6)
- Population‐Based Signals of Antidepressant Drug Interactions Associated With Unintentional Traumatic Injury (2021) (5)
- Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation (2021) (4)
- Prevalence and Factors Associated With Fecal Urgency Among Patients With Ulcerative Colitis and Crohn’s Disease in the Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease (2021) (4)
- Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis. (2022) (3)
- Apixaban has superior effectiveness and safety compared to rivaroxaban in patients with commercial healthcare coverage: A population‐based analysis in response to CVS 2022 formulary changes (2022) (3)
- Twelve‐year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States (2020) (2)
- Comparative Safety of Dipeptidyl Peptidase‐4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population‐Based Cohort Studies (2021) (2)
- Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study” (2018) (2)
- Signals of Muscle Relaxant Drug Interactions Associated with Unintentional Traumatic Injury: A Population-Based Screening Study (2022) (2)
- Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis. (2020) (1)
- Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease (2022) (1)
- Population-based screening to detect benzodiazepine drug-drug-drug interaction signals associated with unintentional traumatic injury (2022) (1)
- Skeletal muscle relaxant drug–drug–drug interactions and unintentional traumatic injury: Screening to detect three‐way drug interaction signals (2022) (1)
- P127 FACTORS ASSOCIATED WITH FECAL URGENCY IN INFLAMMATORY BOWEL DISEASE PATIENTS: A CROSS-SECTIONAL STUDY FROM SPARC IBD (2020) (0)
- Identifying Clinically Relevant Drug–Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection (2022) (0)
- Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation A population-based analysis. (2021) (0)
- Comparative Effectiveness Of Apixaban Versus Warfarin For The Prevention Of Recurrent Venous Thromboembolism And Cardiovascular Diseases In Patients With Venous Thromboembolism (2018) (0)
- IMPACT OF WORK AND ACTIVITY LIMITATIONS ATTRIBUTABLE TO ARTHRITIS ON HEALTH-RELATED QUALITY OF LIFE IN UNITED STATES VETERANS (2016) (0)
- Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's Disease (2022) (0)
- Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation (2021) (0)
- The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome. (2021) (0)
- Can apixaban prevent venous thromboembolism better than rivaroxaban? - Authors' reply. (2019) (0)
- Sa1570: MORE THAN 2.6 MILLION CASES OF PROVIDER-DIAGNOSED INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES (2022) (0)
- Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease (2022) (0)
- Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less (2021) (0)
- Trends in post-discharge prophylactic anticoagulant use among stroke patients in the United States between 2006 and 2019. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ghadeer K Dawwas?
Ghadeer K Dawwas is affiliated with the following schools:
